Imagine receiving a letter from a company offering to let you license a patent covering a computer-related business method for $50,000. Should you pay it? What if the company claims that its patent ...

(RTTNews) - Biogen Inc. (BIIB), an American company focused on the therapies for the treatment of neurological diseases said it intends to seek re-examination of negative opinion adopted by European ...

Fiona Yin of Saint Island International Patent & Law Offices says patent applicants should consider the Accelerated Examination Procedure for Re-examination as it offers an easier application process ...

Anavex Life Sciences faces a negative CHMP opinion on Anavex 2-73 for Alzheimer's, with re-examination unlikely to improve approval odds. AVXL's Phase 2B/3 trial failed to achieve statistical ...

Protalix BioTherapeutics, Inc. (NYSE:PLX) announced 3Q:25 financial and operational results in a November 13th, 2025, press release and in its Form 10-Q filing. The reports were followed by a ...

PARMA, Italy and CARMIEL, Israel, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Chiesi Global Rare Diseases, a business unit of the Chiesi Group, and Protalix BioTherapeutics, Inc. (NYSE American: PLX), have ...

Counsel at four firms reveal whether data on USPTO trends reflects the work they saw last year and why, despite an overall dip in PTAB activity, they are as busy as ever Ex-parte re-examinations have ...

In 2018, Johannes Vermeer’s Girl with a Pearl Earring (c. 1665, Mauritshuis) underwent a technical examination within the research project "The Girl in the Spotlight". The painting was examined in ...

There’s no rest for Magma Design Automation’s legal team this holiday season. The Santa Clara, Calif.-based EDA tool provider Wednesday filed a second request with the U.S. Patent and Trademark Office ...

Speculation about the National Eligibility-cum-Entrance Test-Undergraduate (NEET-UG) 2024 exam being re-conducted is at an all-time high due to the continuous stream of petitions being submitted to ...